4.4 Article

Transferrin receptors targeting peptide (T7 peptide) surface-modified sorafenib nanoliposomes enhance the anti-tumor effect in colorectal cancer

Related references

Note: Only part of the references are listed.
Review Medicine, Research & Experimental

Recent Therapeutic Advances in the Treatment of Colorectal Cancer

Kristen K. Ciombor et al.

ANNUAL REVIEW OF MEDICINE, VOL 66 (2015)

Article Multidisciplinary Sciences

Enhanced anti-ischemic stroke of ZL006 by T7-conjugated PEGylated liposomes drug delivery system

Zhongyuan Wang et al.

SCIENTIFIC REPORTS (2015)

Article Chemistry, Multidisciplinary

Poly(lactide-co-glycolide) microspheres for MRI-monitored transcatheter delivery of sorafenib to liver tumors

Jeane Chen et al.

JOURNAL OF CONTROLLED RELEASE (2014)

Article Medicine, Research & Experimental

Synergistic Dual-Ligand Doxorubicin Liposomes Improve Targeting and Therapeutic Efficacy of Brain Glioma in Animals

Taili Zong et al.

MOLECULAR PHARMACEUTICS (2014)

Article Oncology

Cancer statistics, 2013

Rebecca Siegel et al.

CA-A CANCER JOURNAL FOR CLINICIANS (2013)

Article Biochemistry & Molecular Biology

Rationally Designed Multitarget Anticancer Agents

Zhuo Chen et al.

CURRENT MEDICINAL CHEMISTRY (2013)

Article Ophthalmology

Combination of Targeted PDT and Anti-VEGF Therapy for Rat CNV by RGD-Modified Liposomal Photocyanine and Sorafenib

Jia-lin Wang et al.

INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2013)

Article Nanoscience & Nanotechnology

Preparation, in vitro release, and pharmacokinetics in rabbits of lyophilized injection of sorafenib solid lipid nanoparticles

Hong Zhang et al.

INTERNATIONAL JOURNAL OF NANOMEDICINE (2012)

Review Chemistry, Multidisciplinary

Nanoscale Metal-Organic Frameworks for Biomedical Imaging and Drug Delivery

Joseph Della Rocca et al.

ACCOUNTS OF CHEMICAL RESEARCH (2011)

Article Oncology

Global Cancer Statistics

Ahmedin Jemal et al.

CA-A CANCER JOURNAL FOR CLINICIANS (2011)

Article Medicine, Research & Experimental

Peptide-Conjugated PAMAM for Targeted Doxorubicin Delivery to Transferrin Receptor Overexpressed Tumors

Liang Han et al.

MOLECULAR PHARMACEUTICS (2010)

Editorial Material Chemistry, Multidisciplinary

Composite Nanoparticles Take Aim at Cancer

Pilar Rivera Gil et al.

ACS NANO (2008)

Review Nanoscience & Nanotechnology

Nanocarriers as an emerging platform for cancer therapy

Dan Peer et al.

NATURE NANOTECHNOLOGY (2007)

Article Oncology

Improving penetration in tumors with nanoassemblies of phospholipids and doxorubicin

Ning Tang et al.

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2007)

Article Hematology

Transferrin receptor 2 is frequently expressed in human cancer cell lines

Alessia Calzolari et al.

BLOOD CELLS MOLECULES AND DISEASES (2007)

Article Biochemistry & Molecular Biology

Receptor mediated uptake of peptides that bind the human transferrin receptor

JH Lee et al.

EUROPEAN JOURNAL OF BIOCHEMISTRY (2001)